Are Big Pharma making moves in Cell and Gene Therapy? Find out in this month's Commercial Insight bit.ly/1oiPXa4 @CGT_Insights

Successful clinical trial offers hope of cure for sickle cell disease through stem cell transplantation bit.ly/1MmwPij @CGT_Insights

Is human embryo gene editing using CRISPR/Cas9 on the cards in the UK?bit.ly/1MmwyvA @CGT_Insights

Chromatin reprogramming induces the formation of embryonic-like totipotent cells bit.ly/1eUD7sU @CGT_Insights

Chemicals found to improve bone marrow transplant efficiency bit.ly/1OI5xDn @CGT_Insights @Nature

Genetically altered T cells – a promising treatment for multiple myeloma bit.ly/1Dvnpe4 @CGT_Insights

Bone marrow-derived progenitor cells may contribute to adipogenesis bit.ly/1GvF05D @CGT_Insights ow.ly/i/bXuNc

Bone marrow-derived progenitor cells contribute to adipogenesis bit.ly/1GvF05D @CGT_Insights

‘Mini bile ducts’ enable diseae modelling for drug screening bit.ly/1HDlV5B @CGT_Insights

Stem cell derived brain organoids provide insight into autism bit.ly/1KeRYtH @CGT_Insights

Visual pathway strengthening capacity of gene therapy revealed @CGT_Insights bit.ly/1RHMI8E

Ets transcription factors could prevent gliomagenesis, study finds bit.ly/1JaceOj @CGT_Insights @CellReports